Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Notes underwriting agrmnt
Inv. presentation
Asset disposition
Appointed CFO
Quarterly results
Director departure
Appointed director
|
|
ARCA biopharma, Inc. (ABIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Granted 6,000 options to buy
@ $2.32, valued at
$13.9k
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Ma-Weaver Jacob (10% Owner) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Granted 12,000 options to buy
@ $2.27, valued at
$27.2k
|
|
| 05/25/2022 |
4
| Funicular Fund, LP (See Footnote 1) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 2,301 shares
@ $2.295, valued at
$5.3k
Bought 18,110 shares
@ $2.2851, valued at
$41.4k
Bought 64,851 shares
@ $2.3244, valued at
$150.7k
|
|
| 05/20/2022 |
4
| Funicular Fund, LP (See Footnote 1) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 13,072 shares
@ $2.3046, valued at
$30.1k
Bought 1 shares
@ $2.25, valued at
$2.3 |
|
| 05/16/2022 |
4
| Funicular Fund, LP (See Footnote 1) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 27,922 shares
@ $2.2698, valued at
$63.4k
Bought 14,000 shares
@ $2.2942, valued at
$32.1k
Bought 42,914 shares
@ $2.2987, valued at
$98.6k
|
|
| 05/11/2022 |
4
| Funicular Fund, LP (See Footnote 1) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 20,979 shares
@ $2.2845, valued at
$47.9k
Bought 24,596 shares
@ $2.285, valued at
$56.2k
|
|
| 05/09/2022 |
4
| Funicular Fund, LP (See Footnote 1) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 16,903 shares
@ $2.2747, valued at
$38.4k
Bought 57,998 shares
@ $2.2827, valued at
$132.4k
Bought 49,221 shares
@ $2.2698, valued at
$111.7k
|
|
| 05/02/2022 |
4
| Funicular Fund, LP (See Footnote 1) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 23,381 shares
@ $2.3169, valued at
$54.2k
Bought 8,974 shares
@ $2.3004, valued at
$20.6k
Bought 1,259 shares
@ $2.315, valued at
$2.9k
|
|
| 04/27/2022 |
4
| Funicular Fund, LP (See Footnote 1) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 13,751 shares
@ $2.2913, valued at
$31.5k
Sold 7,500 options to buy
@ $2.5, valued at
$18.8k
|
|
| 04/20/2022 |
4
| Funicular Fund, LP (See Footnote 1) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 9,119 shares
@ $2.3117, valued at
$21.1k
Sold 7,000 options to buy
@ $2.5, valued at
$17.5k
|
|
| 04/14/2022 |
4
| Funicular Fund, LP (See Footnote 1) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 17,410 shares
@ $2.3289, valued at
$40.5k
|
|
| 04/12/2022 |
4
| Funicular Fund, LP (See Footnote 1) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 30,660 shares
@ $2.3109, valued at
$70.9k
Bought 4,655 shares
@ $2.315, valued at
$10.8k
Bought 69,398 shares
@ $2.3214, valued at
$161.1k
|
|
| 04/07/2022 |
4
| Funicular Fund, LP (See Footnote 1) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 49,728 shares
@ $2.3019, valued at
$114.5k
Bought 26,806 shares
@ $2.2981, valued at
$61.6k
Bought 27,450 shares
@ $2.3208, valued at
$63.7k
|
|
| 04/04/2022 |
4
| Funicular Fund, LP (See Footnote 1) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 122,342 shares
@ $2.2585, valued at
$276.3k
|
|
| 12/16/2021 |
4
| Ozeroff Christopher David (S.V.P., General Counsel) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Granted 27,500 options to buy
@ $2.29, valued at
$63k
|
|
| 12/16/2021 |
4
| Keuer Thomas A (COO) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.29, valued at
$80.2k
|
|
| 12/16/2021 |
4
| Dekker C. Jeffrey (CFO) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Granted 17,700 options to buy
@ $2.29, valued at
$40.5k
|
|
| 12/16/2021 |
4
| BRISTOW MICHAEL R (Pres. & Chief Executive Offic) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Granted 95,000 options to buy
@ $2.29, valued at
$217.6k
|
|
| 11/23/2021 |
4
| Ozeroff Christopher David (S.V.P., General Counsel) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 50,000 shares
@ $2.2642, valued at
$113.2k
|
|
| 05/13/2021 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 10,000 shares
@ $3.1947, valued at
$31.9k
|
|
| 05/06/2021 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 10,000 shares
@ $3.2345, valued at
$32.3k
|
|
| 01/13/2021 |
4
| Hove Anders D (Director) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Granted 12,000 options to buy
@ $4.31, valued at
$51.7k
|
|
| 01/13/2021 |
4
| Woosley Raymond L. (Director) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Granted 12,000 options to buy
@ $4.31, valued at
$51.7k
|
|
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2021 |
4
| MITCHELL DANIEL J (Director) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Granted 12,000 options to buy
@ $4.31, valued at
$51.7k
|
|
|
|
|